Using Off-Label Communications to Responsibly Advance the Public Health

被引:0
|
作者
Peter J. Pitts
机构
[1] Center for Medicine in the Public Interest,
来源
Therapeutic Innovation & Regulatory Science | 2017年 / 51卷
关键词
DTC; off-label communication; Amarin; Caronia; free speech;
D O I
暂无
中图分类号
学科分类号
摘要
The debate over off-label communications doesn’t begin or end with the Caronia or Amarin decisions. It’s a continuing dialogue between manufacturers and the FDA, between doctors and patients, between doctors and academics, between lawyers and judges, and between advocates on all sides. And the red thread that ties these conversations together is responsible off-label communications. Not sales strategies. Not Direct-to-Consumer (DTC) advertising and marketing tactics. Not managed market negotiations—the responsible sharing of truthful and accurate information via nonregulated speech. Off-label communications, properly done, advances precision medicine, delivering speedier positive patient outcomes and reducing costs to our health care system. Off-label communications provides patients with more options for effective medicines.
引用
收藏
页码:322 / 326
页数:4
相关论文
共 50 条
  • [31] OFF-LABEL PRESCRIBING OF ANTIDEPRESSANTS Robust systems are needed for off-label prescribing
    Ross, Samantha
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 356
  • [32] Off-label use in cardiac surgery ["Off-label use" in der Herzchirurgie]
    Fenger H.
    Löher A.
    Sindermann J.R.
    Scheld H.H.
    Schmidt C.
    Hoffmeier A.
    Zeitschrift für Herz-,Thorax- und Gefäßchirurgie, 2009, 23 (6) : 345 - 348
  • [33] Off-Label Use vs Off-Label Marketing Part 2: Off-Label Marketing- Consequences for Patients, Clinicians, and Researchers
    Van Norman, Gail A.
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2023, 8 (03): : 359 - 370
  • [34] Off-label or Off-limits?
    Ritchey, Michael L.
    JOURNAL OF UROLOGY, 2013, 190 (01): : 8 - 9
  • [35] Off-label or off-limits?
    Mark Ratner
    Trisha Gura
    Nature Biotechnology, 2008, 26 : 867 - 875
  • [36] Off-label or off-limits?
    Ratner, Mark
    Gura, Trisha
    NATURE BIOTECHNOLOGY, 2008, 26 (08) : 867 - 875
  • [37] Off-Label Use vs Off-Label Marketing of Drugs Part 1: Off-Label Use-Patient Harms and Prescriber Responsibilities
    Van Norman, Gail A.
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2023, 8 (02): : 224 - 233
  • [38] Going Off-label Without Venturing Off-Course Evidence and Ethical Off-label Prescribing
    Largent, Emily A.
    Miller, Franklin G.
    Pearson, Steven D.
    ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (19) : 1745 - 1747
  • [39] Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics
    Christian Lenk
    Philipp Koch
    Hildegard Zappel
    Claudia Wiesemann
    European Journal of Pediatrics, 2009, 168 : 1473 - 1478
  • [40] Off-label use and G-BA. Legal framework for off-label use
    Brucklacher, U.
    Brockmeyer, N. H.
    Riedel, C.
    HAUTARZT, 2013, 64 (10): : 736 - 742